NO985820L - Cytokinproduksjonsinhibitor, triazepinforbindelse og mellomprodukter for disse - Google Patents
Cytokinproduksjonsinhibitor, triazepinforbindelse og mellomprodukter for disseInfo
- Publication number
- NO985820L NO985820L NO985820A NO985820A NO985820L NO 985820 L NO985820 L NO 985820L NO 985820 A NO985820 A NO 985820A NO 985820 A NO985820 A NO 985820A NO 985820 L NO985820 L NO 985820L
- Authority
- NO
- Norway
- Prior art keywords
- cytokine production
- heteroaryl
- aryl
- formula
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
- C07D255/04—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17426896 | 1996-06-12 | ||
JP9523797 | 1997-03-28 | ||
PCT/JP1997/002016 WO1997047622A1 (fr) | 1996-06-12 | 1997-06-11 | Inhibiteurs de production de cytokines, composes triazepine et intermediaires correspondants |
Publications (2)
Publication Number | Publication Date |
---|---|
NO985820D0 NO985820D0 (no) | 1998-12-11 |
NO985820L true NO985820L (no) | 1999-02-01 |
Family
ID=26436510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO985820A NO985820L (no) | 1996-06-12 | 1998-12-11 | Cytokinproduksjonsinhibitor, triazepinforbindelse og mellomprodukter for disse |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0934940A1 (fr) |
CN (1) | CN1227555A (fr) |
AU (1) | AU3106197A (fr) |
BR (1) | BR9710453A (fr) |
CA (1) | CA2258053A1 (fr) |
IL (1) | IL127516A0 (fr) |
NO (1) | NO985820L (fr) |
PL (1) | PL330635A1 (fr) |
WO (1) | WO1997047622A1 (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1375465A4 (fr) * | 2001-04-03 | 2006-01-11 | Eisai Co Ltd | Derive de cyclooctanone et derive de cyclodecanone et utilisation de ces derives |
WO2005089800A1 (fr) * | 2004-03-17 | 2005-09-29 | Locomogene, Inc. | COMPOSITION PHARMACEUTIQUE CONTENANT DE LA hsHRD3 |
PT2722334E (pt) * | 2009-11-05 | 2016-03-11 | Glaxosmithkline Llc | Inibidor do bromodomínio da benzodiazepina |
GB0919426D0 (en) * | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
DK2496582T3 (en) * | 2009-11-05 | 2016-03-21 | Glaxosmithkline Llc | Benzodiazepine-BROMDOMAeNEINHIBITOR. |
AU2015203454B2 (en) * | 2009-11-05 | 2017-02-23 | Glaxosmithkline Llc | Benzodiazepine bromodomain inhibitor |
ES2539964T3 (es) * | 2009-11-05 | 2015-07-07 | Glaxosmithkline Llc | Procedimiento novedoso |
EP2571503B1 (fr) * | 2010-05-14 | 2015-01-07 | Dana-Farber Cancer Institute, Inc. | Compositions et leur utilisation dans le traitement des néoplasies, des maladies inflammatoires et d'autres affections |
AU2015201727B2 (en) * | 2010-05-14 | 2018-03-08 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
JP6022442B2 (ja) | 2010-05-14 | 2016-11-09 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | 男性用避妊組成物および使用方法 |
CA2799403C (fr) | 2010-05-14 | 2020-01-21 | Dana-Farber Cancer Institute, Inc. | Compositions et methodes de traitement de la leucemie |
JP5715241B2 (ja) * | 2010-05-14 | 2015-05-07 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
ES2526671T3 (es) | 2010-06-22 | 2015-01-14 | Glaxosmithkline Llc | Compuestos de benzotriazoldiazepina inhibidores de bromodominios |
TWI549955B (zh) * | 2010-08-04 | 2016-09-21 | 達納 法柏癌症學院有限公司 | 治療腫瘤形成、發炎疾病及其他病症之組成物及方法 |
AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
WO2012075456A1 (fr) | 2010-12-02 | 2012-06-07 | Constellation Pharmaceuticals | Inhibiteurs de bromodomaines et leurs utilisations |
EP2705039B1 (fr) | 2011-05-04 | 2017-07-26 | Constellation Pharmaceuticals, Inc. | Inhibiteurs de bromodomaines et leurs utilisations |
WO2012174487A2 (fr) | 2011-06-17 | 2012-12-20 | Constellation Pharmaceuticals, Inc. | Inhibiteurs à bromodomaine et leurs utilisations |
DE102011082013A1 (de) | 2011-09-01 | 2013-03-07 | Bayer Pharma AG | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
CN102603743B (zh) | 2012-02-24 | 2014-05-28 | 南京天易生物科技有限公司 | 抗肿瘤的氮杂苯并[f]薁衍生物其制备方法及其用途 |
EP2864336B1 (fr) | 2012-06-06 | 2016-11-23 | Constellation Pharmaceuticals, Inc. | Inhibiteurs de bromo-domaine de benzo[b]isoxazoloazépines et applications associées |
TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
MX2015001880A (es) | 2012-08-16 | 2015-05-11 | Bayer Pharma AG | 2,3-benzodiacepinas. |
EP2900672B1 (fr) | 2012-09-28 | 2017-02-22 | Bayer Pharma Aktiengesellschaft | 5-aryl-triazolo-azépines inhibitrice de la protéine bet |
AU2014292888B2 (en) | 2013-07-25 | 2018-03-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcription factors and uses thereof |
CN105849110B (zh) | 2013-11-08 | 2019-08-02 | 达纳-法伯癌症研究所有限公司 | 使用溴结构域和额外终端(bet)蛋白抑制剂的用于癌症的组合疗法 |
CA2936865A1 (fr) | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Derives de diaminopyrimidine benzenesulfone et leurs utilisations |
EP3099693A4 (fr) | 2014-01-31 | 2017-08-16 | Dana-Farber Cancer Institute, Inc. | Utilisations des dérivés de diazépane |
SG11201607108XA (en) | 2014-02-28 | 2016-09-29 | Tensha Therapeutics Inc | Treatment of conditions associated with hyperinsulinaemia |
US9969747B2 (en) | 2014-06-20 | 2018-05-15 | Constellation Pharmaceuticals, Inc. | Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide |
CN106793775B (zh) | 2014-08-08 | 2020-06-02 | 达纳-法伯癌症研究所股份有限公司 | 二氢碟啶酮衍生物及其用途 |
CA2955074A1 (fr) | 2014-08-08 | 2016-02-11 | Dana-Farber Cancer Institute, Inc. | Derives de diazepane et leurs utilisations |
US9975901B2 (en) * | 2014-10-02 | 2018-05-22 | Glaxosmithkline Intellectual Property (No. 2) Limited | Crystalline solid state form of the benzene sulphonic acid salt of 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide |
UA122130C2 (uk) | 2014-10-27 | 2020-09-25 | Тенша Терапеутікс, Інк. | Інгібітори бромодомену |
WO2016201370A1 (fr) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Thérapie d'association utilisant des inhibiteurs de transcription et des inhibiteurs de kinases |
CN108472299A (zh) | 2015-09-11 | 2018-08-31 | 达纳-法伯癌症研究所股份有限公司 | 乙酰胺噻吩并***并二氮杂环庚三烯及其用途 |
KR20180049058A (ko) | 2015-09-11 | 2018-05-10 | 다나-파버 캔서 인스티튜트 인크. | 시아노 티에노트리아졸로디아제핀 및 그의 용도 |
SG11201803210YA (en) | 2015-11-25 | 2018-05-30 | Dana Farber Cancer Inst Inc | Bivalent bromodomain inhibitors and uses thereof |
EP3518898A4 (fr) * | 2016-10-03 | 2020-06-17 | The Children's Medical Center Corporation | Prévention et traitement de néphropathie diabétique |
EP3640253A4 (fr) * | 2017-05-31 | 2021-01-13 | AYUMI Pharmaceutical Corporation | Dérivé de 6h-thiéno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazépine |
BR112020025003A2 (pt) | 2018-06-13 | 2021-03-23 | Dybly Ag | preparação de derivados de triazepina condensados e uso dos mesmos como inibidores de bet |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1489980A (en) * | 1975-01-20 | 1977-10-26 | Upjohn Co | Reaction products of 3-amino-3,4-dihydro-4-hydroxy-4-phenylquinazolines |
US4144233A (en) * | 1977-02-16 | 1979-03-13 | The Dow Chemical Company | Method for preparing benzo-(1,3,4)-benzotriazepines |
HUT77349A (hu) * | 1994-11-18 | 1998-03-30 | Japan Tobacco Inc. | Eljárás csontritkulás kezelésére alkalmas kondenzált triazepinszármazékokat tartalmazó gyógyszerkészítmények előállítására, valamint új kondenzált triazepinszármazékok és intermedierjeik |
JP2622673B2 (ja) * | 1994-11-18 | 1997-06-18 | 日本たばこ産業株式会社 | 骨粗鬆症治療薬およびトリアゼピン化合物 |
-
1997
- 1997-06-11 CN CN97197090.4A patent/CN1227555A/zh active Pending
- 1997-06-11 IL IL12751697A patent/IL127516A0/xx unknown
- 1997-06-11 BR BR9710453A patent/BR9710453A/pt unknown
- 1997-06-11 PL PL97330635A patent/PL330635A1/xx unknown
- 1997-06-11 AU AU31061/97A patent/AU3106197A/en not_active Abandoned
- 1997-06-11 WO PCT/JP1997/002016 patent/WO1997047622A1/fr not_active Application Discontinuation
- 1997-06-11 CA CA002258053A patent/CA2258053A1/fr not_active Abandoned
- 1997-06-11 EP EP97926224A patent/EP0934940A1/fr not_active Withdrawn
-
1998
- 1998-12-11 NO NO985820A patent/NO985820L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9710453A (pt) | 1999-08-17 |
WO1997047622A1 (fr) | 1997-12-18 |
IL127516A0 (en) | 1999-10-28 |
AU3106197A (en) | 1998-01-07 |
CN1227555A (zh) | 1999-09-01 |
EP0934940A1 (fr) | 1999-08-11 |
PL330635A1 (en) | 1999-05-24 |
NO985820D0 (no) | 1998-12-11 |
CA2258053A1 (fr) | 1997-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO985820L (no) | Cytokinproduksjonsinhibitor, triazepinforbindelse og mellomprodukter for disse | |
TW359670B (en) | Process for producing quinazolin-4-one derivatives | |
DK135791A (da) | 1h-imidazooe4,5-caaquinolin-4-amin, farmaceutisk praeparat indeholdende en saadan forbindelse og fremga ngsmaade til fremstilling af forbindelsen | |
DE69903976T2 (de) | Heteroaryl-zyklische acetale | |
FI935672A0 (fi) | Substituerade pyrazoler | |
DK633088A (da) | Kollagenaseinhibitorer | |
PL307090A1 (en) | Derivatives of o-benzyl oxime ether and their application as pesticides | |
NO986180L (no) | Nye amidinoderivater og deres anvendelse som trombininhibitorer | |
NZ333957A (en) | Compounds able to displace tritiated cis-N-cyclohexyl-N-ethyl[3-(3-chloro-4-cyclohexyphenyl)-allyl]amine | |
EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
ES2154605A1 (es) | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 | |
ES2106936T3 (es) | Derivados de carbazolona y procedimientos para su preparacion. | |
DK0763024T3 (da) | Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater | |
HRP20020440B1 (en) | 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof | |
MY130750A (en) | Pyrimidine derivatives useful as selective cox-2 inhibitors | |
IT1201454B (it) | 1,4-diidropiridine-2-sostituite | |
FI834410A (fi) | Foerfarande foer framstaellning av pyrimidinonderivat. | |
DK67582A (da) | Fremgangsmaade til fremstilling af aroylimidazol-2-oner | |
CA2203850A1 (fr) | Nouveau n-phenyl-n-phenyliminonethylbenzamidines et de leurs analogues de nouveaux agonistes du recepteur muscarinique | |
DE59703603D1 (de) | Pteridinderivate als NO Synthase-Hemmer | |
IT1255207B (it) | Composizioni farmaceutuche ad attivita' antiaggregante e vasodilatatrice | |
ES2195787A1 (es) | Compuestos capaces de bloquear la respuesta a sustancias quimicas o estimulos termicos o mediadores de la inflamacion de los nociceptores, un metodo para su obtencion y composiciones que los continen. | |
NO20023513D0 (no) | Anvendelse av et ekstraheringsmiddel som et antiskummiddel ved fremstilling av vannfri maursyre | |
DE3560829D1 (de) | Enkephalinase inhibitors | |
KR20000016732A (en) | Cytokine production inhibitors, triazepine compounds, and intermediates thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |